Transplantation for renal amyloidosis

Area of Science:

• Nephrology
• Transplantation Immunology
• Genetics

Background:

• Amyloid nephropathy, frequently associated with familial Mediterranean fever (FMF) in Turkey, presents a controversial indication for renal transplantation due to disease prognosis.
• Renal transplantation for amyloid nephropathy was initiated in January 1985.

Purpose of the Study:

• To evaluate the efficacy and outcomes of renal transplantation in patients suffering from amyloid nephropathy.
• To determine if renal transplantation for amyloid nephropathy yields survival rates comparable to other renal failure etiologies.

Main Methods:

• A retrospective analysis of 18 renal transplantations performed for amyloid nephropathy between January 1985 and the study period.
• Assessment of graft function and patient survival with a mean follow-up of 34.6 months.

Main Results:

• Fourteen of the 18 renal grafts remained functional, with creatinine levels between 1-3.2 mg/dL.
• The 1-year patient survival rate was 88.9%, and the 1-year graft survival rate was 83.0%.
• These survival rates were statistically comparable to those of renal transplantations for other causes of end-stage renal disease.

Conclusions:

• Renal transplantation is a viable and effective treatment option for patients with end-stage renal failure caused by amyloidosis.
• Patients with amyloidosis-related renal failure demonstrate comparable outcomes post-transplantation to patients with other renal failure conditions, challenging previous controversies.